Return to content in this issue


Anaphylaxis Management in the GALAXIA 2022 Update

Prieto-Moreno A1,2*, Puente-Crespo Y2,3*, Cardona V2,4, de la Hoz B5,6,7, Dieguez MC8,9, González-de-Olano D5,6, Habernau A10, Perales-Chorda C2,11**, Muñoz-Cano R2,12,13,14,15*

1Allergy Department, Hospital Universitario Infanta Leonor, Madrid, Spain
2Anaphylaxis Committee of the Spanish Society of Allergology and Clinical Immunology (SEAIC)
3Allergy Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain
4Allergy Section, Department of Internal Medicine, Hospital Vall d’Hebron, Barcelona, Spain
5Allergy Department, Hospital Universitario Ramón y Cajal, Madrid Spain
6Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
7Universidad de Alcala de Henares, Madrid, Spain
8Allergy Department, Madrid, Spain
9Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain
10Department of Allergy, Complejo Hospitalario de Mérida, Mérida, Spain
11Allergy Department, Hospital de Sagunto, Valencia, Spain
12Allergy Department, Hospital Clinic, Barcelona, Spain
13Institut d’Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain
14Universitat de Barcelona, Barcelona, Spain
*Contributed equally as first author.
**Contributed equally as last author.

J Investig Allergol Clin Immunol 2023; Vol 33(6) : 486-487
doi: 10.18176/jiaci.0962

Key words: Adrenaline, Anaphylaxis, Guidelines, GALAXIA